IVME
Price:
$0.0001
Market Cap:
$6.04K
In Veritas Medical Diagnostics, Inc., a development stage company, engages in the research and development of medical devices with `near-patient' testing applications. Its primary product includes prothrombin monitor, which is used for the measurement of coagulation of blood in patients at risk of heart disease and stroke. The company's other products under development include predictor of labor onset, a consumer device for maternity planning; biomarker monitor for the measurement of a number of biomarkers, including heart attack, HIV, cholesterol, and cancer; blood glucose monitor, a noninvasive glucose concentration continuous bulk measuring device measurement; digital scanning machine, a ...[Read more]
Industry
Shell Companies
IPO Date
2004-07-14
Stock Exchange
PNK
Ticker
IVME
According to In Veritas Medical Diagnostics, Inc.’s latest financial reports and current stock price. The company's current ROE is 63.26%. This represents a change of 467.85% compared to the average of 11.14% of the last 4 quarters.
The mean historical ROE of In Veritas Medical Diagnostics, Inc. over the last ten years is 37.13%. The current 63.26% ROE has changed 70.40% with respect to the historical average. Over the past ten years (40 quarters), IVME's ROE was at its highest in in the December 2003 quarter at 42.06%. The ROE was at its lowest in in the October 2004 quarter at 5.86%.
Average
37.13%
Median
46.30%
Minimum
-32.61%
Maximum
88.52%
Discovering the peaks and valleys of In Veritas Medical Diagnostics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 30.25%
Maximum Annual ROE = 88.52%
Minimum Annual Increase = -371.44%
Minimum Annual ROE = -32.61%
Year | ROE | Change |
---|---|---|
2007 | 52.38% | 30.25% |
2006 | 40.22% | -54.57% |
2005 | 88.52% | -371.44% |
The current ROE of In Veritas Medical Diagnostics, Inc. (IVME) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
60.37%
5-year avg
37.13%
10-year avg
37.13%
In Veritas Medical Diagnostics, Inc.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like In Veritas Medical Diagnostics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like In Veritas Medical Diagnostics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is In Veritas Medical Diagnostics, Inc.'s ROE?
How is the ROE calculated for In Veritas Medical Diagnostics, Inc. (IVME)?
What is the highest ROE for In Veritas Medical Diagnostics, Inc. (IVME)?
What is the 3-year average ROE for In Veritas Medical Diagnostics, Inc. (IVME)?
What is the 5-year average ROE for In Veritas Medical Diagnostics, Inc. (IVME)?
How does the current ROE for In Veritas Medical Diagnostics, Inc. (IVME) compare to its historical average?